Shockwave Medical Inc
NASDAQ:SWAV
Shockwave Medical Inc
NASDAQ:SWAV
Price:
330.63 USD
0.03%
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Shockwave Medical Inc
Shockwave Medical Inc
| Current Assets | 1.2B |
| Cash & Short-Term Investments | 990.6m |
| Receivables | 114.6m |
| Other Current Assets | 120.2m |
| Non-Current Assets | 341.3m |
| Long-Term Investments | 1.6m |
| PP&E | 98.6m |
| Intangibles | 132.4m |
| Other Non-Current Assets | 108.6m |
| Current Liabilities | 104.2m |
| Accounts Payable | 8.9m |
| Accrued Liabilities | 83m |
| Other Current Liabilities | 12.3m |
| Non-Current Liabilities | 793.7m |
| Long-Term Debt | 731.9m |
| Other Non-Current Liabilities | 61.8m |
Balance Sheet
Shockwave Medical Inc
Shockwave Medical Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
52
|
40
|
139
|
50
|
89
|
157
|
328
|
|
| Cash Equivalents |
52
|
40
|
139
|
50
|
89
|
157
|
328
|
|
| Short-Term Investments |
2
|
0
|
56
|
152
|
112
|
148
|
662
|
|
| Total Receivables |
1
|
3
|
7
|
12
|
37
|
71
|
115
|
|
| Accounts Receivables |
1
|
3
|
7
|
12
|
37
|
71
|
115
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
5
|
12
|
30
|
43
|
75
|
108
|
|
| Other Current Assets |
1
|
1
|
2
|
2
|
5
|
8
|
13
|
|
| Total Current Assets |
58
|
49
|
217
|
246
|
286
|
459
|
1 225
|
|
| PP&E Net |
1
|
3
|
14
|
24
|
52
|
81
|
99
|
|
| PP&E Gross |
1
|
3
|
14
|
24
|
52
|
81
|
99
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
6
|
10
|
17
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
93
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
40
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
6
|
4
|
2
|
|
| Other Long-Term Assets |
0
|
2
|
2
|
2
|
2
|
103
|
109
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
40
|
|
| Total Assets |
59
N/A
|
53
-10%
|
232
+334%
|
272
+17%
|
346
+27%
|
646
+87%
|
1 567
+142%
|
|
| Liabilities | ||||||||
| Accounts Payable |
1
|
2
|
3
|
2
|
4
|
7
|
9
|
|
| Accrued Liabilities |
3
|
6
|
15
|
21
|
43
|
53
|
83
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
2
|
7
|
3
|
6
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
4
|
12
|
|
| Total Current Liabilities |
5
|
9
|
24
|
26
|
52
|
63
|
104
|
|
| Long-Term Debt |
0
|
13
|
7
|
13
|
12
|
24
|
732
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Other Liabilities |
1
|
0
|
8
|
8
|
41
|
47
|
58
|
|
| Total Liabilities |
5
N/A
|
23
+355%
|
39
+69%
|
46
+18%
|
104
+124%
|
135
+30%
|
898
+566%
|
|
| Equity | ||||||||
| Common Stock |
138
|
153
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
86
|
127
|
178
|
244
|
253
|
37
|
110
|
|
| Additional Paid In Capital |
3
|
4
|
371
|
469
|
495
|
549
|
558
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Equity |
54
N/A
|
30
-44%
|
193
+538%
|
226
+17%
|
242
+7%
|
511
+111%
|
669
+31%
|
|
| Total Liabilities & Equity |
59
N/A
|
53
-10%
|
232
+334%
|
272
+17%
|
346
+27%
|
646
+87%
|
1 567
+142%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
27
|
27
|
31
|
35
|
35
|
36
|
37
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
